Wall Street Zen upgraded shares of Agape ATP (NASDAQ:ATPC – Free Report) to a hold rating in a research report sent to investors on Saturday morning.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a report on Wednesday, January 21st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.
Check Out Our Latest Report on Agape ATP
Agape ATP Trading Up 8.7%
Institutional Inflows and Outflows
An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC raised its stake in Agape ATP Corporation (NASDAQ:ATPC – Free Report) by 95.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 0.01% of the company’s stock.
Agape ATP Company Profile
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.
Read More
- Five stocks we like better than Agape ATP
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
